JCB, Volume 21, Number 1, 2015 Article Vol.21 No. 1 (2015) Reverse Stock Splits in the Biotechnology Industry: An Effectuation Approach Wei Wu Using an effectuation theory lens, we study reverse stock splits in the biotech industry where significant uncertainty makes specific scenarios of success difficult to predict. We conject Article Vol.21 No. 1 (2015) Debt and Taxes: Marginal Tax Rate Changes, Capital Structure, and Innovative Activity in the Biotechnology Sector Grant H Skrepnek The purpose of this investigation was to examine the association between changes in corporate marginal tax rat Article Vol.21 No. 1 (2015) Industrial Application of Biological Self-healing Concrete: Challenges and Economical Feasibility Filipe Bravo Silva Self-healing concrete has been scrutinized by several researchers and some industrial concrete producers in relation to the remediation of the occurrence of micro-cracks. Article Vol.21 No. 1 (2015) Differentiating Public Policy for Technology Startups – Essential for Biotech? Mindaugas Kiškis The paper presents the limited quantitative and qualitative analysis of the biotechnology and ICT industries in Lithuania and Estonia, as well as public policy instruments aimed at suppor From the Classroom Vol.21 No. 1 (2015) Using Biotechnology, CSI, and Zombies to Promote Science Education in one of America’s Most Challenging Regions David Eugene Menshew This paper examines the creation of a forensic biotechnology program that engages students, promotes science learning beyond the classroom and makes available novel STEM opportunities to Case Study Vol.21 No. 1 (2015) Cell Therapy: Early Process Development and Optimization of the Manufacturing Process are Critical to Ensure Viability of the Product, Quality, Consistency and Cost Efficiency Ohad Karnieli In recent years cell therapies have evolved and matured, moving from academia to industry. Scale up of a process is the natural path of any product evolutionary development and maturation From the Boardroom Vol.21 No. 1 (2015) Access to Innovation Peter J. Pitts Healthcare innovation saves lives, saves money, promotes economic growth, and provides hope for hundreds of millions of people (both patients and care-givers) in the United States and aro From the Boardroom Vol.21 No. 1 (2015) Characteristics of Great Bioscience Leaders Steve McLaughlin Good leaders in the biosciences share multiple characteristics, starting with certain personality traits – some that are particularly unique and important to the bioscience sector. Legal and Regulatory Updates Vol.21 No. 1 (2015) EU Legal and Regulatory Update Henry Elliott
